Public Policy Committee

The committee recommends advocacy issues and activities and identifies critical areas for AMIA's strategic advocacy engagement for Board approval. The committee works with AMIA’s policy consultant, staff, and Board to develop annual work plans which support the strategic directions set by the Board. The committee also takes the lead in developing draft policy comments in support of AMIA positions. The committee reports to the Executive Committee.

Margo Edmunds, Chair, AcademyHealth
Susie Aguirre, AMIA
Greg L. Alexander, University of Missouri-Columbia
David W. Bates, Brigham and Women's Hospital
Michael N. Cantor, Pfizer Pharmaceuticals
Christopher G. Chute, Mayo Clinic College of Medicine
Don E. Detmer
Brian E. Dixon, Regenstrief Institute, Inc.
Judith A. Effken, University of Arizona
Mark E. Frisse, Vanderbilt University
Paul Fu, Jr., Harbor-UCLA
Karen Greenwood, AMIA
Scott Haber, Washington Health Strategies Group
Thomson M. Kuhn, ACP
Christoph U. Lehmann, Vanderbilt University
Ross Martin, AMIA
Brandon Maughan, University of Pennsylvania
John D. McGreevey, University of Pennsylvania Health System
Genevieve B. Melton-Meaux, University of Minnesota
Douglas Peddicord, Washington Health Strategies Group, Oldaker, Belair & Wittie
Carolyn Petersen, Mayo Clinic
Mark J Segal, GE Healthcare IT
Charlotte A. Weaver, Gentiva Health Services
Laura Wiley, Vanderbilt University
Adam Wright, Brigham & Women's Hospital